Evidence map›Paper›PMID 22396479›Full record

ArticlemBio2012

Local response to microneedle-based influenza immunization in the skin.

Maria del Pilar Martin, William C Weldon, Vladimir G Zarnitsyn, Dimitrios G Koutsonanos, Hamed Akbari, Ioanna Skountzou, Joshy Jacob, Mark R Prausnitz, Richard W Compans

Open access · goldAbstract read
In one paragraph

Article in mBio, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 72 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Vaccine delivery systems toward lymph nodes.Advanced drug delivery reviews · 2021
    Review
  6. Article
  7. Review
  8. Progress in microneedle array patch (MAP) for vaccine delivery.Human vaccines & immunotherapeutics · 2021
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Microneedles coated with peanut allergen enable desensitization of peanut sensitized mice.Journal of controlled release : official journal of the Controlled Release Society · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Stable incorporation of GM-CSF into dissolvable microneedle patch improves skin vaccination against influenza.Journal of controlled release : official journal of the Controlled Release Society · 2018
    Article
  18. Article
  19. Article
  20. The success of microneedle-mediated vaccine delivery into skin.Human vaccines & immunotherapeutics · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Maria del Pilar MartinDepartment of Microbiology and Immunology, Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia, USA.
William C Weldon
Vladimir G Zarnitsyn
Dimitrios G Koutsonanos
Hamed Akbari
Ioanna Skountzou
Joshy Jacob
Mark R Prausnitz
Richard W Compans
Emory University · USGeorgia Institute of Technology · USEmory and Henry College · US

Funding

Influenza vaccination using a microneedle patchU01EB012495 · NIBIB · GEORGIA INSTITUTE OF TECHNOLOGY · PI PRAUSNITZ, MARK R. · 2010 to 2015
$9.6M
Self-administered microneedle patches for influenza vaccinesU01AI074579 · NIAID · EMORY UNIVERSITY · PI COMPANS, RICHARD W · 2007 to 2011
$7.7M
Microneedle-based immunization against pandemic influenzaR01EB006369 · NIBIB · GEORGIA INSTITUTE OF TECHNOLOGY · PI PRAUSNITZ, MARK R. · 2007 to 2011
$3.6M
NIAID NIH HHS AI074579NIAID NIH HHS HHSN266200700006CNIAID NIH HHS U01 AI074579NIBIB NIH HHS EB006369NIBIB NIH HHS EB012495NIBIB NIH HHS R01 EB006369NIBIB NIH HHS U01 EB012495
6 · The paper itself

Abstract

unlabelledMicroneedle patches (MN) provide a novel method of vaccine delivery to the skin with the objective of targeting the large network of resident antigen-presenting cells to induce an efficient immune response. Our previous reports demonstrated that cutaneous delivery of inactivated influenza virus-coated MN to mice protects against lethal infection. Protection is correlated with sustained levels of anti-influenza virus serum antibodies, hemagglutination inhibition titers, and robust cellular responses that are often stronger than those generated by intramuscular vaccination. Here we dissect the early events occurring in murine skin after microneedle delivery of inactivated influenza virus. We demonstrate correlation of immunization against influenza virus with a local increase of cytokines important for recruitment of neutrophils, monocytes and dendritic cells at the site of immunization. We also observed prolonged antigen deposition, and migration of matured dendritic cells bearing influenza virus antigen from the skin. IMPORTANCE: The immunological mechanisms by which MN vaccination confers protective immunity are not well understood. The present study provides a first analysis of the early immune events after microneedle-based vaccination.

Indexed as

AnimalsCytokinesDendritic CellsFemaleFlow CytometryImmunizationInfluenza VaccinesInjections, IntradermalMiceMice, Inbred BALB CMice, NudeMonocytesNeutrophilsSkinVaccines, InactivatedWhole Body ImagingCytokinesInfluenza VaccinesVaccines, Inactivated

Identifiers

PMID22396479
PMCPMC3302568
OpenAlexW2106865625

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.